Description

Influenza virus (inactivated, split) of the following strains*: A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09 – like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909) 15 micrograms HA**; A/Hong Kong/2671/2019 (H3N2) – like strain (A/Hong Kong/2671/2019, IVR-208) 15 micrograms HA**; B/Washington/02/2019 – like strain (B/Washington/02/2019, wild type) 15 micrograms HA**; B/Phuket/3073/2013 – like strain (B/Phuket/3073/2013, wild type) 15 micrograms HA** for one 0.5 ml dose.
* propagated in fertilised hens’ eggs from healthy chicken flocks.
** haemagglutinin.
This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU decision for the 2020/2021 season.
VaxigripTetra may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see Contraindications).
Excipients/Inactive Ingredients: Buffer Solution: Sodium chloride, Potassium chloride, Disodium phosphate dihydrate, Potassium dihydrogen phosphate, Water for injections.